Rugo HS, Kok M, Goncalves A, Loirat D, et al. Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1?Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. Ann Oncol 2026 Oct 24:S0923-7534(26)08077-4. doi: 10.1016/j.annonc.2026.10.1285.
PMID: 42926111